Skip to main content

Table 11 Estimate of treatment effect of all hemorrhagic complication stratified for hip vs knee adjusted for effects of age, gender, and NSAID and hetastarch used

From: Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study

 

Adjusted odds ratio(95 % CI)

p-value

Hip

Fondaparinux vs. variable dose warfarin

0.45 (0.14-1.44)

0.238

 

Fixed dose warfarin vs. variable dose warfarin

0.40 (0.12-1.32)

0.170

 

Fixed dose warfarin vs. fondaparinux

0.89 (0.24-3.3645)

0.978

Knee

Fondaparinux vs. variable dose warfarin

3.45 (1.15-10.32)

0.022

 

Fixed dose warfarin vs. variable dose warfarin

1.78 (0.56-5.68)

0.471

 

Fixed dose warfarin vs. fondaparinux

0.52 (0.20-1.36)

0.248